AF
ADPT icon

Advisornet Financial’s Adaptive Biotechnologies ADPT Stock Holding History

Advisornet Financial’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,250
Closed -$109K – 1711
2020
Q2 		$109K Buy
+2,250
New +$82K 0.01% 647

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Advisornet Financial's ADPT Position: Q3 2020 in Review

Advisornet Financial sold out of Adaptive Biotechnologies (ADPT) in Q3 2020, closing a stake of 2,250 shares — an estimated $109K sold.

Advisornet Financial first reported a position in ADPT in Q2 2020 and held it in 1 quarter. The position peaked at $109K in Q2 2020. 206 funds tracked by Wall St. Rank hold ADPT as of Q3 2020.

  • Advisornet Financial reported no remaining Adaptive Biotechnologies position as of Q3 2020 after selling out during the quarter.
  • Advisornet Financial sold 2,250 Adaptive Biotechnologies shares in Q3 2020, an estimated $109K.
  • Advisornet Financial first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 1 quarter.
  • Advisornet Financial's Adaptive Biotechnologies position peaked at $109K in Q2 2020.
  • 206 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2020.

Based on Advisornet Financial's 13F filing for Q3 2020, filed 6 Nov 2020.